{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:40:38Z","timestamp":1774543238024,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772103"],"award-info":[{"award-number":["81772103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172234"],"award-info":[{"award-number":["82172234"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00266-023-03279-1","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T21:52:47Z","timestamp":1677016367000},"page":"1587-1597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Salvianolic Acid B Attenuates Hypertrophic Scar Formation In Vivo and In Vitro"],"prefix":"10.1007","volume":"47","author":[{"given":"Chio-Hou","family":"Chong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Ming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Tung","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan-Ning","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"3279_CR1","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cps.2017.05.006","volume":"44","author":"S Agarwal","year":"2017","unstructured":"Agarwal S, Sorkin M, Levi B (2017) Heterotopic ossification and hypertrophic scars. Clin Plast Surg 44:749\u2013755","journal-title":"Clin Plast Surg"},{"key":"3279_CR2","doi-asserted-by":"publisher","first-page":"eabb3312","DOI":"10.1126\/scitranslmed.abb3312","volume":"13","author":"MF Griffin","year":"2021","unstructured":"Griffin MF, Borrelli MR, Garcia JT, Januszyk M, King M, Lerbs T, Cui L, Moore AL, Shen AH, Mascharak S, Deleon NMD, Adem S, Taylor WL, DesJardins-Park HE, Gastou M, Patel RA, Duoto BA, Sokol J, Wei Y, Foster D, Chen K, Wan DC, Gurtner GC, Lorenz HP, Chang HY, Wernig G, Longaker MT (2021) JUN promotes hypertrophic skin scarring via CD36 in preclinical in vitro and in vivo models. Sci Transl Med 13:eabb3312","journal-title":"Sci Transl Med"},{"key":"3279_CR3","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(16)31406-4","volume":"388","author":"CC Finnerty","year":"2016","unstructured":"Finnerty CC, Jeschke MG, Branski LK, Barret JP, Dziewulski P, Herndon DN (2016) Hypertrophic scarring: the greatest unmet challenge after burn injury. Lancet 388:1427\u20131436","journal-title":"Lancet"},{"key":"3279_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3390\/ijms19030711","volume":"19","author":"HJ Lee","year":"2018","unstructured":"Lee HJ, Jang YJ (2018) Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and keloids. Int J Mol Sci 19:711","journal-title":"Int J Mol Sci"},{"key":"3279_CR5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.burns.2012.09.020","volume":"39","author":"R Fredman","year":"2013","unstructured":"Fredman R, Tenenhaus M (2013) Cushing\u2019s syndrome after intralesional triamcinolone acetonide: a systematic review of the literature and multinational survey. Burns 39:549\u2013557","journal-title":"Burns"},{"key":"3279_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/lsm.23301","volume":"53","author":"J Tan","year":"2021","unstructured":"Tan J, Zhou J, Huang L, Fu Q, Ao M, Yuan L, Luo G (2021) Hypertrophic scar improvement by early intervention with ablative fractional carbon dioxide laser treatment. Lasers Surg Med 53:450\u2013457","journal-title":"Lasers Surg Med"},{"key":"3279_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/DSS.0000000000000306","volume":"41","author":"AM Van Drooge","year":"2015","unstructured":"Van Drooge AM, Vrijman C, Van Der Veen W, Wolkerstorfer A (2015) A randomized controlled pilot study on ablative fractional CO2 laser for consecutive patients presenting with various scar types. Dermatol Surg 41:371\u2013377","journal-title":"Dermatol Surg"},{"key":"3279_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s41038-019-0175-y","volume":"7","author":"R Ogawa","year":"2019","unstructured":"Ogawa R, Akita S, Akaishi S, Aramaki-Hattori N, Dohi T, Hayashi T, Kishi K, Kono T, Matsumura H, Muneuchi G, Murao N, Nagao M, Okabe K, Shimizu F, Tosa M, Tosa Y, Yamawaki S, Ansai S, Inazu N, Kamo T, Kazki R, Kuribayashi S (2019) Diagnosis and treatment of keloids and hypertrophic scars-Japan scar workshop consensus document 2018. Burns Trauma 7:39","journal-title":"Burns Trauma"},{"key":"3279_CR9","doi-asserted-by":"publisher","first-page":"79e","DOI":"10.1097\/PRS.0000000000008667","volume":"149","author":"R Ogawa","year":"2022","unstructured":"Ogawa R (2022) The most current algorithms for the treatment and prevention of hypertrophic scars and keloids: a 2020 update of the algorithms published 10 years ago. Plast Reconstr Surg 149:79e\u201394e","journal-title":"Plast Reconstr Surg"},{"key":"3279_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2119\/molmed.2009.00153","volume":"17","author":"GG Gauglitz","year":"2011","unstructured":"Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG (2011) Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17:113\u2013125","journal-title":"Mol Med"},{"key":"3279_CR11","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00018-015-2110-0","volume":"73","author":"IA Darby","year":"2016","unstructured":"Darby IA, Zakuan N, Billet F, Desmouliere A (2016) The myofibroblast, a key cell in normal and pathological tissue repair. Cell Mol Life Sci 73:1145\u20131157","journal-title":"Cell Mol Life Sci"},{"key":"3279_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/bjd.14108","volume":"174","author":"YF Zhang","year":"2016","unstructured":"Zhang YF, Zhou SZ, Cheng XY, Yi B, Shan SZ, Wang J, Li QF (2016) Baicalein attenuates hypertrophic scar formation via inhibition of the transforming growth factor-beta\/Smad2\/3 signalling pathway. Br J Dermatol 174:120\u2013130","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"3279_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/DSS.0000000000000819","volume":"43","author":"B Berman","year":"2017","unstructured":"Berman B, Maderal A, Raphael B (2017) Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg 43(Suppl 1):3\u201318","journal-title":"Dermatol Surg"},{"key":"3279_CR14","doi-asserted-by":"publisher","first-page":"1605456","DOI":"10.1155\/2020\/1605456","volume":"2020","author":"QQ Ji","year":"2020","unstructured":"Ji QQ, Li YJ, Wang YH, Wang Z, Fang L, Shen L, Lu YQ, Shen LH, He B (2020) Salvianolic acid B improves postresuscitation myocardial and cerebral outcomes in a murine model of cardiac arrest: involvement of Nrf2 signaling pathway. Oxid Med Cell Longev 2020:1605456","journal-title":"Oxid Med Cell Longev"},{"key":"3279_CR15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12906-016-1275-x","volume":"16","author":"D Li","year":"2016","unstructured":"Li D, Wang J, Hou J, Fu J, Liu J, Lin R (2016) Salvianolic acid B induced upregulation of miR-30a protects cardiac myocytes from ischemia\/reperfusion injury. BMC Complement Altern Med 16:336","journal-title":"BMC Complement Altern Med"},{"key":"3279_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2131\/jts.46.199","volume":"46","author":"Z Lin","year":"2021","unstructured":"Lin Z, Bao Y, Hong B, Wang Y, Zhang X, Wu Y (2021) Salvianolic acid B attenuated cisplatin-induced cardiac injury and oxidative stress via modulating Nrf2 signal pathway. J Toxicol Sci 46:199\u2013207","journal-title":"J Toxicol Sci"},{"key":"3279_CR17","doi-asserted-by":"publisher","first-page":"114389","DOI":"10.1016\/j.jep.2021.114389","volume":"279","author":"FHP Tan","year":"2021","unstructured":"Tan FHP, Ting ACJ, Leow BG, Najimudin N, Watanabe N, Azzam G (2021) Alleviatory effects of danshen, salvianolic acid A and salvianolic acid B on PC12 neuronal cells and drosophila melanogaster model of Alzheimer\u2019s disease. J Ethnopharmacol 279:114389","journal-title":"J Ethnopharmacol"},{"key":"3279_CR18","doi-asserted-by":"publisher","first-page":"572373","DOI":"10.3389\/fphar.2020.572373","volume":"11","author":"Z Xiao","year":"2020","unstructured":"Xiao Z, Liu W, Mu YP, Zhang H, Wang XN, Zhao CQ, Chen JM, Liu P (2020) Pharmacological effects of salvianolic acid b against oxidative damage. Front Pharmacol 11:572373","journal-title":"Front Pharmacol"},{"key":"3279_CR19","doi-asserted-by":"publisher","first-page":"174408","DOI":"10.1016\/j.ejphar.2021.174408","volume":"909","author":"D Wang","year":"2021","unstructured":"Wang D, Lu X, Wang E, Shi L, Ma C, Tan X (2021) Salvianolic acid B attenuates oxidative stress-induced injuries in enterocytes by activating Akt\/GSK3beta signaling and preserving mitochondrial function. Eur J Pharmacol 909:174408","journal-title":"Eur J Pharmacol"},{"key":"3279_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s13287-021-02575-4","volume":"12","author":"JM Sun","year":"2021","unstructured":"Sun JM, Ho CK, Gao Y, Chong CH, Zheng DN, Zhang YF, Yu L (2021) Salvianolic acid-B improves fat graft survival by promoting proliferation and adipogenesis. Stem Cell Res Ther 12:507","journal-title":"Stem Cell Res Ther"},{"key":"3279_CR21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.biopha.2018.12.016","volume":"110","author":"Q Liu","year":"2019","unstructured":"Liu Q, Lu J, Lin J, Tang Y, Pu W, Shi X, Jiang S, Liu J, Ma Y, Li Y, Xu J, Jin L, Wang J, Wu W (2019) Salvianolic acid B attenuates experimental skin fibrosis of systemic sclerosis. Biomed Pharmacother 110:546\u2013553","journal-title":"Biomed Pharmacother"},{"key":"3279_CR22","doi-asserted-by":"publisher","first-page":"116881","DOI":"10.1016\/j.lfs.2019.116881","volume":"239","author":"C Wu","year":"2019","unstructured":"Wu C, Chen W, Ding H, Li D, Wen G, Zhang C, Lu W, Chen M, Yang Y (2019) Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2\/3at linker regions in vivo and in vitro. Life Sci 239:116881","journal-title":"Life Sci"},{"key":"3279_CR23","doi-asserted-by":"publisher","first-page":"110241","DOI":"10.1016\/j.biopha.2020.110241","volume":"128","author":"Y He","year":"2020","unstructured":"He Y, Lu R, Wu J, Pang Y, Li J, Chen J, Liu B, Zhou Y, Zhou J (2020) Salvianolic acid B attenuates epithelial-mesenchymal transition in renal fibrosis rats through activating Sirt1-mediated autophagy. Biomed Pharmacother 128:110241","journal-title":"Biomed Pharmacother"},{"key":"3279_CR24","doi-asserted-by":"publisher","first-page":"111475","DOI":"10.1016\/j.biopha.2021.111475","volume":"138","author":"T Zhang","year":"2021","unstructured":"Zhang T, Liu M, Gao Y, Li H, Song L, Hou H, Chen T, Ma L, Zhang G, Ye Z (2021) Salvianolic acid B inhalation solution enhances antifibrotic and anticoagulant effects in a rat model of pulmonary fibrosis. Biomed Pharmacother 138:111475","journal-title":"Biomed Pharmacother"},{"key":"3279_CR25","first-page":"1917","volume":"41","author":"L Tu","year":"2018","unstructured":"Tu L, Huang Q, Fu S, Liu D (2018) Aberrantly expressed long noncoding RNAs in hypertrophic scar fibroblasts in vitro: a microarray study. Int J Mol Med 41:1917\u20131930","journal-title":"Int J Mol Med"},{"key":"3279_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.matbio.2018.01.019","volume":"68\u201369","author":"P Pakshir","year":"2018","unstructured":"Pakshir P, Hinz B (2018) The big five in fibrosis: macrophages, myofibroblasts, matrix, mechanics, and miscommunication. Matrix Biol 68\u201369:81\u201393","journal-title":"Matrix Biol"},{"key":"3279_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41419-019-1333-7","volume":"10","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Wang J, Zhou S, Xie Z, Wang C, Gao Y, Zhou J, Zhang X, Li Q (2019) Flavones hydroxylated at 5, 7, 3\u2019 and 4\u2019 ameliorate skin fibrosis via inhibiting activin receptor-like kinase 5 kinase activity. Cell Death Dis 10:124","journal-title":"Cell Death Dis"},{"key":"3279_CR28","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/art.38380","volume":"66","author":"H Kudo","year":"2014","unstructured":"Kudo H, Jinnin M, Asano Y, Trojanowska M, Nakayama W, Inoue K, Honda N, Kajihara I, Makino K, Fukushima S, Ihn H (2014) Decreased interleukin-20 expression in scleroderma skin contributes to cutaneous fibrosis. Arthritis Rheumatol 66:1636\u20131647","journal-title":"Arthritis Rheumatol"},{"key":"3279_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/08982104.2019.1593451","volume":"30","author":"J Shi","year":"2020","unstructured":"Shi J, Guo S, Wu Y, Chen G, Lai J, Xu X (2020) Behaviour of cell penetrating peptide TAT-modified liposomes loaded with salvianolic acid B on the migration, proliferation, and survival of human skin fibroblasts. J Liposome Res 30:93\u2013106","journal-title":"J Liposome Res"},{"key":"3279_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/cells8060607","volume":"8","author":"AL Rippa","year":"2019","unstructured":"Rippa AL, Kalabusheva EP, Vorotelyak EA (2019) Regeneration of dermis: scarring and cells involved. Cells 8:607","journal-title":"Cells"},{"key":"3279_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/00006534-200108000-00022","volume":"108","author":"GS Chin","year":"2001","unstructured":"Chin GS, Liu W, Peled Z, Lee TY, Steinbrech DS, Hsu M, Longaker MT (2001) Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg 108:423\u2013429","journal-title":"Plast Reconstr Surg"},{"key":"3279_CR32","doi-asserted-by":"publisher","first-page":"110287","DOI":"10.1016\/j.biopha.2020.110287","volume":"129","author":"T Zhang","year":"2020","unstructured":"Zhang T, Wang XF, Wang ZC, Lou D, Fang QQ, Hu YY, Zhao WY, Zhang LY, Wu LH, Tan WQ (2020) Current potential therapeutic strategies targeting the TGF-beta\/Smad signaling pathway to attenuate keloid and hypertrophic scar formation. Biomed Pharmacother 129:110287","journal-title":"Biomed Pharmacother"},{"key":"3279_CR33","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s00210-021-02114-1","volume":"394","author":"J Yang","year":"2021","unstructured":"Yang J, Gong Y, Xu W, Li L, Shi Z, Wang Q, He Y, Zhang C, Luo C, Fang Z, Yang Y (2021) Smad3 gene C-terminal phosphorylation site mutation exacerbates CCl4-induced hepatic fibrogenesis by promoting pSmad2L\/C-mediated signaling transduction. Naunyn Schmiedebergs Arch Pharmacol 394:1779\u20131786","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3279_CR34","doi-asserted-by":"publisher","first-page":"27610","DOI":"10.1038\/srep27610","volume":"6","author":"Q Liu","year":"2016","unstructured":"Liu Q, Chu H, Ma Y, Wu T, Qian F, Ren X, Tu W, Zhou X, Jin L, Wu W, Wang J (2016) Salvianolic acid B attenuates experimental pulmonary fibrosis through inhibition of the TGF-beta signaling pathway. Sci Rep 6:27610","journal-title":"Sci Rep"},{"key":"3279_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2121-11-31","volume":"11","author":"QL Wang","year":"2010","unstructured":"Wang QL, Tao YY, Yuan JL, Shen L, Liu CH (2010) Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-beta1 signal transduction pathway in vivo and in vitro. BMC Cell Biol 11:31","journal-title":"BMC Cell Biol"},{"key":"3279_CR36","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1096\/fj.07-8218com","volume":"21","author":"S Aarabi","year":"2007","unstructured":"Aarabi S, Bhatt KA, Shi Y, Paterno J, Chang EI, Loh SA, Holmes JW, Longaker MT, Yee H, Gurtner GC (2007) Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J 21:3250\u20133261","journal-title":"FASEB J"},{"key":"3279_CR37","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/jdv.16028","volume":"34","author":"T Shao","year":"2020","unstructured":"Shao T, Tang W, Li Y, Gao D, Lv K, He P, Song Y, Gao S, Liu M, Chen Y, Yi Z (2020) Research on function and mechanisms of a novel small molecule WG449E for hypertrophic scar. J Eur Acad Dermatol Venereol 34:608\u2013618","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3279_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejphar.2019.02.039","volume":"852","author":"X Ye","year":"2019","unstructured":"Ye X, Pang Z, Zhu N (2019) Dihydromyricetin attenuates hypertrophic scar formation by targeting activin receptor-like kinase 5. Eur J Pharmacol 852:58\u201367","journal-title":"Eur J Pharmacol"},{"key":"3279_CR39","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11010-015-2644-3","volume":"413","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Shan S, Wang J, Cheng X, Yi B, Zhou J, Li Q (2016) Galangin inhibits hypertrophic scar formation via ALK5\/Smad2\/3 signaling pathway. Mol Cell Biochem 413:109\u2013118","journal-title":"Mol Cell Biochem"},{"key":"3279_CR40","doi-asserted-by":"publisher","first-page":"152871","DOI":"10.1016\/j.phymed.2019.152871","volume":"58","author":"Q Jia","year":"2019","unstructured":"Jia Q, Zhu R, Tian Y, Chen B, Li R, Li L, Wang L, Che Y, Zhao D, Mo F, Gao S, Zhang D (2019) Salvia miltiorrhiza in diabetes: a review of its pharmacology, phytochemistry, and safety. Phytomedicine 58:152871","journal-title":"Phytomedicine"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-023-03279-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00266-023-03279-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-023-03279-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T16:18:02Z","timestamp":1690820282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00266-023-03279-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["3279"],"URL":"https:\/\/doi.org\/10.1007\/s00266-023-03279-1","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"assertion":[{"value":"2 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Shanghai Ninth People's Hospital and complied with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All patients provided informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}